This Week in BMC Cancer | GenomeWeb

This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in Japan report on a trial of customized chemotherapy for elderly non-small-cell lung cancer patients based on their EGFR mutation status. The team screened 57 chemotherapy-naïve patients, aged 70 years or older, with confirmed non-small-cell lung cancer — they gave 22 patients with EGFR mutations gefitinib and 32 patients without EGFR mutations vinorelbine or gemcitabine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.